AI assistant
Sending…
Alector, Inc. — Director's Dealing 2020
Apr 17, 2020
33290_dirs_2020-04-17_23c3fe29-83f5-4ec2-975f-deff2cbb3e24.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Alector, Inc. (ALEC)
CIK: 0001653087
Period of Report: 2020-04-15
Reporting Person: Paul Robert (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-15 | Common Stock | S | 10000 | $22.27 | Disposed | 243719 | Direct |
Footnotes
F1: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan.
F2: The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $21.86 to $22.64 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
More from Alector, Inc.
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
May 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 26
Annual Report
2026
Feb 25
Earnings Release
2026
Feb 25